. 2020 Oct 16;31(3):1376–1380. doi: 10.1007/s11695-020-05049-3

Table 2.

Weight loss and changes in comorbidities and in QoL outcomes post RYGB and SG

Weight		RYGB	SG	p
1 year	BMI^a	37.7 (0.79)	39.7 (1.87)	0.27
	Change in BMI^a	7.9 (0.46)	7.3 (0.75)	0.54
	Total weight loss (%)	17.2 (0.97)	15.7 (1.57)	0.42
	EBMIL^b (%)	39.0 (2.35)	35.1 (3.86)	0.40
8 years	BMI^a	32 (0.99)	33.6 (1.75)	0.43
	Change in BMI^a	13.6 (0.94)	13.4 (2.23)	0.93
	Total weight loss (%)	29.2 (1.87)	27.7 (4.16)	0.69
	EBMIL^b (%)	66.8 (4.65)	59.4 (8.41)	0.43
Quality of life scores		RYGB	SG	p
1 year	Self-esteem	0.28 (0.03)	0.24 (0.07)	0.49
	Physical activity	0.19 (0.04)	0.20 (0.07)	0.88
	Social activity	0.25 (0.08)	0.22 (0.07)	0.65
	Work conditions	0.18 (0.05)	0.25 (0.07)	0.44
	Sexual activity	0.10 (0.06)	0.13 (0.10)	0.80
	Relationship to food	0.28 (0.04)	0.27 (0.08)	0.98
	Total	1.27 (0.18)	1.31 (0.40)	0.92
8 year	Self-esteem	0.22 (0.04)	0.11 (0.07)	0.19
	Physical activity	0.10 (0.05)	0.02 (0.07)	0.37
	Social activity	0.25 (0.05)	0.25 (0.07)	0.96
	Work conditions	0.29 (0.06)	0.34 (0.09)	0.68
	Sexual activity	0.09 (0.06)	−0.03 (0.12)	0.35
	Relationship to food	0.25 (0.05)	0.24 (0.07)	0.88
	Total	1.24 (0.21)	0.93 (0.30)	0.45
Comorbidity		RYGB	SG	p
Resolved or improved n (%)	T2DM^c	6 (55)	2 (50)	n/a ^*
	Hypertension	6 (40)	0	n/a ^*
	OSA^d	5 (71)	1 (50)	n/a ^*
	Dyslipidemia	4 (44)	1 (50)	n/a ^*
	GERD^e	5 (36)	0	n/a ^*

Values are expressed as mean (s.e.m.)

^aBMI body mass index, ^bEBMIL excess body mass index loss, ^cT2DM type 2 diabetes mellitus, ^dOSA obstructive sleep apnea syndrome, ^eGERD gastro-oesophageal reflux disease

^*n/a non-applicable—due to the small numbers p value was not calculated